BASF H1 Net Income Plummets 51 Percent to 887 Million Euros EBITDA Down 13 Percent as Chemical Prices Drag
BASF reported sales of €33.2 billion for the first half of 2025, down 1.5% year-on-year, with falling prices in four out of six business segments—especially in chemicals—putting pressure on overall results. The Nutrition & Care and Surface Technologies divisions bucked the trend with price increases, while currency headwinds impacted all areas.
EBITDA fell sharply by 13.4% to €3.7 billion, compared to €4.2 billion in the same period last year, mainly due to weaker chemical segment performance. EBIT dropped 23.4% to €1.7 billion. Net income plunged 50.6% to €887 million, versus €1.8 billion a year earlier.
Operating cash flow was €603 million, a decrease of €834 million year-on-year. Free cash flow came in at negative €1.3 billion, deepening from last year’s negative €986 million. Investment outflows shrank by €1.2 billion, largely because spending on property and equipment—especially for the Zhanjiang site in China—fell by €554 million.
Despite some positive trends in volumes for surface technologies and agricultural solutions, BASF’s overall financials were weighed down by pricing and currency pressures.
2026-09-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Titanium Dioxide: Stuck Between Weak Upside and Limited Downside
-
Shell Plans to Sell U.S. Chemical Assets for Up to $8 Billion, with ExxonMobil and LyondellBasell Joining the Bidding
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Röhm Opens MMA Plant in Texas
-
Wanhua Resumes PO Production: How Much Can Polyether Producers Save on Costs?
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
Röhm Launches New Sulfuric Acid Plant
-
Biochem to Acquire BASF’s Global Glycinates Business
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
Recommend Reading
-
INEOS Inovyn Moths Methyl Chlorocarbonate Production Facility in Tavaux, France
-
BASF Ludwigshafen Workforce Falls Below 30,000, Lowest Level in 72 Years
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
Insufficient Demand for Cyclohexane in China, Weak Market Situation Persists
-
Acesulfame Potassium: Safety, Side Effects, and Food Uses
-
Coke market prices show strong performance in China
-
Following Cost Fluctuations, Polyester Staple Fiber Prices Stop Falling and Rebound
-
DMF Supply Tightens in Early April, Prices Remain Strong